Cargando…

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

The American Diabetes Association, JDRF, the European Association for the Study of Diabetes, and the American Association of Clinical Endocrinologists convened a research symposium, “The Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis” on 10–12 October 2015. Internation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skyler, Jay S., Bakris, George L., Bonifacio, Ezio, Darsow, Tamara, Eckel, Robert H., Groop, Leif, Groop, Per-Henrik, Handelsman, Yehuda, Insel, Richard A., Mathieu, Chantal, McElvaine, Allison T., Palmer, Jerry P., Pugliese, Alberto, Schatz, Desmond A., Sosenko, Jay M., Wilding, John P.H., Ratner, Robert E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384660/ https://www.ncbi.nlm.nih.gov/pubmed/27980006 http://dx.doi.org/10.2337/db16-0806

Ejemplares similares

American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome
por: Semenkovich, Clay F., et al.
Publicado: (2015)

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants
por: Sosenko, Jay M., et al.
Publicado: (2011)

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
por: Sosenko, Jay M., et al.
Publicado: (2020)

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Orban, Tihamer, et al.
Publicado: (2009)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
por: Insel, Richard A., et al.
Publicado: (2015)

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients
por: Sosenko, Jay M., et al.
Publicado: (2013)

Development of Autoantibodies in the TrialNet Natural History Study
por: Vehik, Kendra, et al.
Publicado: (2011)

Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset
por: Ferrannini, Ele, et al.
Publicado: (2010)

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2008)

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants
por: Sosenko, Jay M., et al.
Publicado: (2010)

Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis
por: Xu, Ping, et al.
Publicado: (2012)

Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
por: Ling, Charlotte, et al.
Publicado: (2009)

George S. Eisenbarth: Insulin and Type 1 Diabetes
por: Pugliese, Alberto, et al.
Publicado: (2013)

Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2009)

New Insights into Impaired Muscle Glycogen Synthesis: More a Problem of Muscle Contractility Than of Glucose Tolerance
por: Groop, Leif, et al.
Publicado: (2008)

Genetics of Type 2 Diabetes—Pitfalls and Possibilities
por: Prasad, Rashmi B., et al.
Publicado: (2015)

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood
por: Vehik, Kendra, et al.
Publicado: (2011)

Downregulation of Type II Diabetes Mellitus and Maturity Onset Diabetes of Young Pathways in Human Pancreatic Islets from Hyperglycemic Donors
por: Taneera, Jalal, et al.
Publicado: (2014)

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)
por: Sosenko, Jay M., et al.
Publicado: (2010)

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants
por: Sosenko, Jay M., et al.
Publicado: (2013)

Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes
por: Xu, Ping, et al.
Publicado: (2010)

Prioritizing genes for follow-up from genome wide association studies using information on gene expression in tissues relevant for type 2 diabetes mellitus
por: Parikh, Hemang, et al.
Publicado: (2009)

Influence of Familial Renal Glycosuria Due to Mutations in the SLC5A2 Gene on Changes in Glucose Tolerance over Time
por: Ottosson-Laakso, Emilia, et al.
Publicado: (2016)

Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study
por: Sosenko, Jay M., et al.
Publicado: (2011)

The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes
por: Sosenko, Jay M., et al.
Publicado: (2012)

Erratum. Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785–1787
por: Sosenko, Jay M., et al.
Publicado: (2018)

Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
por: Eckel, Robert H., et al.
Publicado: (2015)

Authors' Reply
por: Lyssenko, Valeriya, et al.
Publicado: (2006)

Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes
por: Dorkhan, Mozhgan, et al.
Publicado: (2009)

1-Hour Post-OGTT Glucose Improves the Early Prediction of Type 2 Diabetes by Clinical and Metabolic Markers
por: Peddinti, Gopal, et al.
Publicado: (2018)

Latent Autoimmune Diabetes in Adults Differs Genetically From Classical Type 1 Diabetes Diagnosed After the Age of 35 Years
por: Andersen, Mette K., et al.
Publicado: (2010)

Calpain-10 Expression Is Elevated in Pancreatic Islets from Patients with Type 2 Diabetes
por: Ling, Charlotte, et al.
Publicado: (2009)

Family history of diabetes and its relationship with insulin secretion and insulin sensitivity in Iraqi immigrants and native Swedes: a population-based cohort study
por: Bennet, Louise, et al.
Publicado: (2017)

Genome editing of human pancreatic beta cell models: problems, possibilities and outlook
por: Balboa, Diego, et al.
Publicado: (2019)

Effects of GIP on regional blood flow during normoglycemia and hyperglycemia in anesthetized rats
por: Gao, Xiang, et al.
Publicado: (2018)

A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History
por: Sosenko, Jay M., et al.
Publicado: (2015)

The insertion/deletion variation in the α(2B)-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes
por: Snapir, Amir, et al.
Publicado: (2003)

The functional impact of G protein-coupled receptor 142 (Gpr142) on pancreatic β-cell in rodent
por: Al-Amily, Israa Mohammad, et al.
Publicado: (2019)

The American Diabetes Association Diabetes Research Perspective
por: Fonseca, Vivian A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hjpo79e287dm1adte2k98mdh6c